DK1158950T3 - antikonvulsive derivater til behandling af essentiel tremor - Google Patents

antikonvulsive derivater til behandling af essentiel tremor

Info

Publication number
DK1158950T3
DK1158950T3 DK00911816T DK00911816T DK1158950T3 DK 1158950 T3 DK1158950 T3 DK 1158950T3 DK 00911816 T DK00911816 T DK 00911816T DK 00911816 T DK00911816 T DK 00911816T DK 1158950 T3 DK1158950 T3 DK 1158950T3
Authority
DK
Denmark
Prior art keywords
treatment
essential tremor
anticonvulsant derivatives
anticonvulsant
derivatives
Prior art date
Application number
DK00911816T
Other languages
English (en)
Inventor
Gregory S Connor
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1158950T3 publication Critical patent/DK1158950T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK00911816T 1999-02-17 2000-02-15 antikonvulsive derivater til behandling af essentiel tremor DK1158950T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17

Publications (1)

Publication Number Publication Date
DK1158950T3 true DK1158950T3 (da) 2006-04-24

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00911816T DK1158950T3 (da) 1999-02-17 2000-02-15 antikonvulsive derivater til behandling af essentiel tremor

Country Status (24)

Country Link
US (1) US6214867B1 (da)
EP (1) EP1158950B1 (da)
JP (1) JP2002539088A (da)
KR (1) KR100664612B1 (da)
CN (1) CN1433306A (da)
AR (1) AR035986A1 (da)
AT (1) ATE316374T1 (da)
AU (1) AU779823B2 (da)
BR (1) BR0008791A (da)
CA (1) CA2362336C (da)
CZ (1) CZ295096B6 (da)
DE (1) DE60025705T2 (da)
DK (1) DK1158950T3 (da)
ES (1) ES2257288T3 (da)
HU (1) HUP0202634A3 (da)
IL (2) IL144943A0 (da)
MX (1) MXPA01008387A (da)
MY (1) MY129238A (da)
NO (1) NO20014026L (da)
NZ (1) NZ513724A (da)
TR (1) TR200103126T2 (da)
TW (1) TWI228413B (da)
WO (1) WO2000048549A2 (da)
ZA (1) ZA200107564B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082222A1 (en) 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
MXPA04002709A (es) * 2001-09-24 2005-06-06 Johnson & Johnson Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
ES2257288T3 (es) 2006-08-01
US6214867B1 (en) 2001-04-10
EP1158950A1 (en) 2001-12-05
TWI228413B (en) 2005-03-01
EP1158950B1 (en) 2006-01-25
KR100664612B1 (ko) 2007-01-04
KR20010112272A (ko) 2001-12-20
DE60025705D1 (de) 2006-04-13
TR200103126T2 (tr) 2002-07-22
NZ513724A (en) 2004-01-30
JP2002539088A (ja) 2002-11-19
IL144943A (en) 2006-08-20
HUP0202634A3 (en) 2005-02-28
MY129238A (en) 2007-03-30
CA2362336C (en) 2005-04-12
CA2362336A1 (en) 2000-08-24
AR035986A1 (es) 2004-08-04
MXPA01008387A (es) 2003-06-06
ZA200107564B (en) 2002-12-13
AU779823B2 (en) 2005-02-10
HUP0202634A2 (hu) 2002-11-28
CZ20013011A3 (cs) 2002-06-12
WO2000048549A3 (en) 2002-04-04
CZ295096B6 (cs) 2005-05-18
NO20014026L (no) 2001-10-17
BR0008791A (pt) 2005-04-05
IL144943A0 (en) 2002-06-30
ATE316374T1 (de) 2006-02-15
WO2000048549A2 (en) 2000-08-24
DE60025705T2 (de) 2006-08-24
AU3364800A (en) 2000-09-04
NO20014026D0 (no) 2001-08-17
CN1433306A (zh) 2003-07-30

Similar Documents

Publication Publication Date Title
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
PT1163237E (pt) Derivados de amida
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
DK1171053T3 (da) Apparat til behandling af tandkaries
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1158950T3 (da) antikonvulsive derivater til behandling af essentiel tremor
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK0970080T3 (da) Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration